RFG Advisory LLC grew its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 25.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,859 shares of the financial services provider's stock after buying an additional 2,394 shares during the quarter. RFG Advisory LLC's holdings in Aflac were worth $1,227,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Aflac by 6.4% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,694,511 shares of the financial services provider's stock worth $524,846,000 after acquiring an additional 281,148 shares in the last quarter. Guinness Asset Management LTD grew its position in shares of Aflac by 5.2% in the fourth quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider's stock valued at $247,682,000 after purchasing an additional 118,720 shares during the period. Truist Financial Corp increased its stake in shares of Aflac by 26.6% during the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider's stock worth $172,338,000 after purchasing an additional 405,847 shares in the last quarter. National Pension Service raised its position in shares of Aflac by 8.9% during the 3rd quarter. National Pension Service now owns 1,662,514 shares of the financial services provider's stock worth $185,869,000 after purchasing an additional 136,238 shares during the last quarter. Finally, Assetmark Inc. lifted its stake in Aflac by 0.7% in the 3rd quarter. Assetmark Inc. now owns 1,584,552 shares of the financial services provider's stock valued at $177,153,000 after buying an additional 10,487 shares in the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.
Shares of Aflac stock opened at $104.82 on Friday. The stock has a 50 day moving average of $105.88 and a 200 day moving average of $105.81. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. The firm has a market capitalization of $58.23 billion, a price-to-earnings ratio of 15.79, a PEG ratio of 2.10 and a beta of 1.00. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.69 by $0.47. The business had revenue of $2.95 billion during the quarter, compared to analysts' expectations of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The company's revenue was down 40.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 EPS. As a group, research analysts predict that Aflac Incorporated will post 7.26 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.21%. This is an increase from Aflac's previous quarterly dividend of $0.50. The ex-dividend date is Wednesday, February 19th. Aflac's payout ratio is 34.94%.
A number of equities analysts have commented on AFL shares. Keefe, Bruyette & Woods reduced their target price on Aflac from $108.00 to $107.00 and set a "market perform" rating for the company in a report on Friday, January 10th. Piper Sandler raised their price objective on Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. BMO Capital Markets began coverage on shares of Aflac in a report on Thursday. They set a "market perform" rating and a $111.00 target price for the company. TD Cowen started coverage on shares of Aflac in a research report on Wednesday, October 9th. They issued a "hold" rating and a $102.00 target price for the company. Finally, Wells Fargo & Company boosted their price target on shares of Aflac from $103.00 to $104.00 and gave the stock an "equal weight" rating in a research report on Tuesday, January 14th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Aflac currently has a consensus rating of "Hold" and an average target price of $102.67.
Get Our Latest Stock Analysis on Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business's stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now owns 222,618 shares of the company's stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.90% of the company's stock.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.